Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay

Previous data suggest that lipophilic statins such as fluvastatin and N-bisphosphonates such as zoledronic acid, both inhibitors of the mevalonate metabolic pathway, have anti-cancer effects in vitro and in patients. We have examined the effect of fluvastatin alone and in combination with zoledronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Louise A, Kurbacher, Christian M, Glaysher, Sharon, Fernando, Augusta, Reichelt, Ralf, Dexel, Susanne, Reinhold, Uwe, Cree, Ian A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642836/
https://www.ncbi.nlm.nih.gov/pubmed/19175937
http://dx.doi.org/10.1186/1471-2407-9-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642836/
https://www.ncbi.nlm.nih.gov/pubmed/19175937
http://dx.doi.org/10.1186/1471-2407-9-38

Ejemplares similares